Ginkgo Bioworks
DNA
174 hedge funds and large institutions have $437M invested in Ginkgo Bioworks in 2025 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 45 increasing their positions, 39 reducing their positions, and 21 closing their positions.
224% more call options, than puts
Call options by funds: $26M | Put options by funds: $8.04M
48% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 21
17% more capital invested
Capital invested by funds: $375M → $437M (+$61.9M)
15% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 39
5% more funds holding
Funds holding: 166 → 174 (+8)
7.85% less ownership
Funds ownership: 71.93% → 64.08% (-7.9%)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$4.4M |
| 2 |
EAM
Erste Asset Management
Vienna,
Austria
|
+$2.39M |
| 3 |
State Street
Boston,
Massachusetts
|
+$2.31M |
| 4 |
Allianz Asset Management
Munich,
Germany
|
+$2.3M |
| 5 |
CAU
Caxton Associates (UK)
London,
|
+$1.55M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$15.9M |
| 2 |
PGCM
Prescott Group Capital Management
Tulsa,
Oklahoma
|
-$8.73M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$5.63M |
| 4 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$5.56M |
| 5 |
JF
Jump Financial
Chicago,
Illinois
|
-$4.22M |
DNA Hedge Fund Activity: Q3 2025 in Review
174 of the 7,640 institutional investors tracked by Wall St. Rank reported a position in Ginkgo Bioworks (DNA) for Q3 2025, worth a combined $437M — up 17% from $375M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new DNA positions and 21 closed out — a net gain of 10 holders — while 45 added to existing stakes and 39 trimmed.
The largest buyer was BlackRock, adding an estimated $4.4M. The largest seller was Millennium Management, cutting an estimated $15.9M.
- 174 institutional investors held Ginkgo Bioworks (DNA) as of Q3 2025, up from 166 in Q2 2025.
- Funds reported $437M of Ginkgo Bioworks stock for Q3 2025, up 17% quarter-over-quarter.
- 31 funds opened new Ginkgo Bioworks positions in Q3 2025 and 21 closed out, a net change of +10 holders.
- The largest Ginkgo Bioworks buyer in Q3 2025 was BlackRock, an estimated $4.4M added.
- The largest Ginkgo Bioworks seller in Q3 2025 was Millennium Management, an estimated $15.9M sold.
Based on aggregated 13F filings for Q3 2025.